Japanese Encephalitis News and Research

RSS
Japanese encephalitis (previously known as Japanese B encephalitis to distinguish it from von Economo's A encephalitis) is a disease caused by the mosquito-borne Japanese encephalitis virus. The Japanese encephalitis virus is a virus from the family Flaviviridae. Domestic pigs and wild birds are reservoirs of the virus; transmission to humans may cause severe symptoms. One of the most important vectors of this disease is the mosquito ''Culex tritaeniorhynchus''. This disease is most prevalent in Southeast Asia and the Far East.
Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine

Beijing CDC selects Sinovac as first priority supplier of seasonal influenza vaccine

Sinovac Biotech receives Drug Registration Certificate for seasonal influenza vaccine

Sinovac Biotech receives Drug Registration Certificate for seasonal influenza vaccine

Intercell reports significant increase in second quarter revenue

Intercell reports significant increase in second quarter revenue

Sinovac Biotech second-quarter 2010 sales increase 131% to $10.3 million

Sinovac Biotech second-quarter 2010 sales increase 131% to $10.3 million

Tamir Biotechnology's three compounds effective show potential for yellow fever

Tamir Biotechnology's three compounds effective show potential for yellow fever

Financial Times examines how GAVI's $2.6B shortfall might affect new vaccine programs in developing countries

Financial Times examines how GAVI's $2.6B shortfall might affect new vaccine programs in developing countries

Saint Louis University conducts research to find safe, effective vaccination for dengue

Saint Louis University conducts research to find safe, effective vaccination for dengue

Sinovac Biotech's sales for first-quarter 2010 decrease 32% to $4.4M

Sinovac Biotech's sales for first-quarter 2010 decrease 32% to $4.4M

Intercell reports EUR 4.8m revenue, EUR 14.7m net loss for first-quarter 2010

Intercell reports EUR 4.8m revenue, EUR 14.7m net loss for first-quarter 2010

Sinovac Biotech's fourth-quarter sales increase 194%

Sinovac Biotech's fourth-quarter sales increase 194%

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Intercell AG's revenues for full year 2009 increase 10.6%

Intercell AG's revenues for full year 2009 increase 10.6%

NanoViricides files quarterly report with Securities and Exchange Commission

NanoViricides files quarterly report with Securities and Exchange Commission

Gentel Biosciences launches integrated Proteomics Multi-System

Gentel Biosciences launches integrated Proteomics Multi-System

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

SVA submits the first clinical trial application for HFMD vaccine in China

SVA submits the first clinical trial application for HFMD vaccine in China

Sinovac Biotech selected as Top 10 most competitive companies for 2009

Sinovac Biotech selected as Top 10 most competitive companies for 2009

Sinovac Biotech receives fourth purchase order for its H1N1 vaccine from Chinese government

Sinovac Biotech receives fourth purchase order for its H1N1 vaccine from Chinese government

Publication serves as a guide to build productive partnerships and overcome global health challenges

Publication serves as a guide to build productive partnerships and overcome global health challenges

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine